Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 3944314
[patent_doc_number] => 05990137
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-23
[patent_title] => 'Method of inhibiting NADPH oxidase'
[patent_app_type] => 1
[patent_app_number] => 9/092461
[patent_app_country] => US
[patent_app_date] => 1998-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10980
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/990/05990137.pdf
[firstpage_image] =>[orig_patent_app_number] => 092461
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/092461 | Method of inhibiting NADPH oxidase | Jun 4, 1998 | Issued |
Array
(
[id] => 3937451
[patent_doc_number] => 05972917
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => '1 .alpha.-hydroxy-25-ene-vitamin D, analogs and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/087439
[patent_app_country] => US
[patent_app_date] => 1998-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9970
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972917.pdf
[firstpage_image] =>[orig_patent_app_number] => 087439
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/087439 | 1 .alpha.-hydroxy-25-ene-vitamin D, analogs and uses thereof | May 28, 1998 | Issued |
Array
(
[id] => 4314311
[patent_doc_number] => 06242434
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => '24-hydroxyvitamin D, analogs and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/086969
[patent_app_country] => US
[patent_app_date] => 1998-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11614
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242434.pdf
[firstpage_image] =>[orig_patent_app_number] => 086969
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/086969 | 24-hydroxyvitamin D, analogs and uses thereof | May 28, 1998 | Issued |
Array
(
[id] => 4089280
[patent_doc_number] => 06133249
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Phospholipid and propylene glycol based lubricant'
[patent_app_type] => 1
[patent_app_number] => 9/077324
[patent_app_country] => US
[patent_app_date] => 1998-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6036
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133249.pdf
[firstpage_image] =>[orig_patent_app_number] => 077324
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/077324 | Phospholipid and propylene glycol based lubricant | May 26, 1998 | Issued |
Array
(
[id] => 1478081
[patent_doc_number] => 06344476
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-05
[patent_title] => 'Inhibition of p38 kinase activity by aryl ureas'
[patent_app_type] => B1
[patent_app_number] => 09/083396
[patent_app_country] => US
[patent_app_date] => 1998-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23390
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/344/06344476.pdf
[firstpage_image] =>[orig_patent_app_number] => 09083396
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/083396 | Inhibition of p38 kinase activity by aryl ureas | May 21, 1998 | Issued |
Array
(
[id] => 3937395
[patent_doc_number] => 05972913
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices'
[patent_app_type] => 1
[patent_app_number] => 9/082237
[patent_app_country] => US
[patent_app_date] => 1998-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3017
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972913.pdf
[firstpage_image] =>[orig_patent_app_number] => 082237
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/082237 | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices | May 19, 1998 | Issued |
09/079644 | 3-[4-(2-PHENYL-INDOLE-1-YLMETHYL)-PHENYL]-ACRYLAMIDE AND ESTROGEN FORMULATIONS | May 14, 1998 | Pending |
09/079604 | 2-PHENYL-1-[4-(AMINO-1-YL-ALK-1-YNYL)-BENZYL]-1H-INDOL-5-OL AND ESTROGEN FORMULATIONS | May 14, 1998 | Pending |
Array
(
[id] => 4183464
[patent_doc_number] => 06020374
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-01
[patent_title] => 'Biologically active synthetic dye compounds'
[patent_app_type] => 1
[patent_app_number] => 9/078495
[patent_app_country] => US
[patent_app_date] => 1998-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 16
[patent_no_of_words] => 5779
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/020/06020374.pdf
[firstpage_image] =>[orig_patent_app_number] => 078495
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/078495 | Biologically active synthetic dye compounds | May 13, 1998 | Issued |
Array
(
[id] => 4217241
[patent_doc_number] => 06087349
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Method for blocking neoplastic transformation of cells induced by ras oncogenes'
[patent_app_type] => 1
[patent_app_number] => 9/081972
[patent_app_country] => US
[patent_app_date] => 1998-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3766
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087349.pdf
[firstpage_image] =>[orig_patent_app_number] => 081972
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/081972 | Method for blocking neoplastic transformation of cells induced by ras oncogenes | May 5, 1998 | Issued |
Array
(
[id] => 4141693
[patent_doc_number] => 06060514
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-09
[patent_title] => 'Isomer enriched conjugated linoleic acid compositions'
[patent_app_type] => 1
[patent_app_number] => 9/072422
[patent_app_country] => US
[patent_app_date] => 1998-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5755
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/060/06060514.pdf
[firstpage_image] =>[orig_patent_app_number] => 072422
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/072422 | Isomer enriched conjugated linoleic acid compositions | May 3, 1998 | Issued |
Array
(
[id] => 4273476
[patent_doc_number] => 06323240
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => '4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity'
[patent_app_type] => 1
[patent_app_number] => 9/068016
[patent_app_country] => US
[patent_app_date] => 1998-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13274
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 245
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323240.pdf
[firstpage_image] =>[orig_patent_app_number] => 068016
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/068016 | 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity | Apr 30, 1998 | Issued |
Array
(
[id] => 1053320
[patent_doc_number] => 06858649
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-22
[patent_title] => 'Selective potentiation of serotonin receptor subtypes'
[patent_app_type] => utility
[patent_app_number] => 09/071389
[patent_app_country] => US
[patent_app_date] => 1998-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 23390
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/858/06858649.pdf
[firstpage_image] =>[orig_patent_app_number] => 09071389
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/071389 | Selective potentiation of serotonin receptor subtypes | Apr 29, 1998 | Issued |
Array
(
[id] => 4118386
[patent_doc_number] => RE036701
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-16
[patent_title] => 'Coronary heart disease treated with oestradiol'
[patent_app_type] => 2
[patent_app_number] => 9/069397
[patent_app_country] => US
[patent_app_date] => 1998-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2196
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/036/RE036701.pdf
[firstpage_image] =>[orig_patent_app_number] => 069397
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/069397 | Coronary heart disease treated with oestradiol | Apr 28, 1998 | Issued |
Array
(
[id] => 4288980
[patent_doc_number] => 06183759
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Cosmetic composition'
[patent_app_type] => 1
[patent_app_number] => 9/066577
[patent_app_country] => US
[patent_app_date] => 1998-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9921
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/183/06183759.pdf
[firstpage_image] =>[orig_patent_app_number] => 066577
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/066577 | Cosmetic composition | Apr 26, 1998 | Issued |
Array
(
[id] => 1248554
[patent_doc_number] => 06673831
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-06
[patent_title] => 'Combination therapy for reducing the risks associated with cardiovascular disease'
[patent_app_type] => B1
[patent_app_number] => 09/067432
[patent_app_country] => US
[patent_app_date] => 1998-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4761
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673831.pdf
[firstpage_image] =>[orig_patent_app_number] => 09067432
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/067432 | Combination therapy for reducing the risks associated with cardiovascular disease | Apr 26, 1998 | Issued |
Array
(
[id] => 1545801
[patent_doc_number] => 06444664
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Method for controlling the plasma level of lipoproteins to treat alzheimeris disease'
[patent_app_type] => B1
[patent_app_number] => 09/062395
[patent_app_country] => US
[patent_app_date] => 1998-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3846
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444664.pdf
[firstpage_image] =>[orig_patent_app_number] => 09062395
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/062395 | Method for controlling the plasma level of lipoproteins to treat alzheimeris disease | Apr 16, 1998 | Issued |
Array
(
[id] => 4185974
[patent_doc_number] => 06159997
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Treatment of arteriosclerosis and xanthoma'
[patent_app_type] => 1
[patent_app_number] => 9/061446
[patent_app_country] => US
[patent_app_date] => 1998-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10743
[patent_no_of_claims] => 210
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159997.pdf
[firstpage_image] =>[orig_patent_app_number] => 061446
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/061446 | Treatment of arteriosclerosis and xanthoma | Apr 15, 1998 | Issued |
09/060419 | ORAL METHOD FOR TREATING OR PREVENTING ABNORMAL BONE RESORPTION | Apr 14, 1998 | Abandoned |
90/004961 | METHOD FOR PREVENTING REDUCING OR RISK OF ONSET OF CEREBROVASCULAR EVENTS EMPLOYING AN HMG COA REDUCTASE INHIBITOR | Apr 8, 1998 | Issued |